The effects of aspirin were independent of age, and sex, and were also seen with a low-dose, slow-release formulation of aspirin designed to inhibit platelets but to have little systemic bioavailability.
FORBES: Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin